American Dental Laser, Inc.
This article was originally published in The Gray Sheet
Executive Summary
Signs a letter of intent granting Minneapolis-based Patterson Dental Company exclusive marketing rights to ADL's KCP 2000 dental treatment device, which FDA cleared for marketing in December 1992. The KCP 2000 "sprays away tooth structure and decay using minute particles of alpha alumina," according to ADL. The firm is positioning the device as an alternative to the drill, saying that "it eliminates a number of time-consuming steps in the placement of tooth-colored fillings and often allows the dentist to treat decay at an earlier stage." Patterson employs 500 direct sales representatives and "equipment specialists" around the country.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.